China approves first oral GLP-1 weight-loss drug
Detailed summary
China on Thursday approved Eli Lilly's orforglipron pills, marketed domestically under the brand name "Muyouda," for long-term weight management in adults, making it the country's…
A Chinese man who weighed 359.4 kilograms, a national record for obesity, has successfully lost 150 kilograms through ...
Weight management has sparked a lot of interest in China as Healthy China 2030 and the promotion of ...
The population of obese people in China is increasing, with over 50 percent of adults being overweight or ...
Opening of the article, excerpted from Global Times. To read the rest, open the article on the publisher's site.
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.globaltimes.cn)
